Purpose. Up to 75 % of all women develop vulvovaginal candidiasis (VVC), with symptoms such as vulvar erythema, pruritus and abnormal vaginal discharge. Despite the global distribution of Candida africana, its role in recurrent vulvovaginal candidiasis (RVVC) is still unclear and requires further investigation. Here, we report on the frequency of C. africana among clinical isolates from patients with RVVC in Bushehr in southern Iran.
INTRODUCTION
Vulvovaginal candidiasis (VVC) is a common fungal infection reflecting abnormal growth of Candida species in the genital mucosa. Up to 75 % of women develop VVC at least once in their lives, and the condition is characterized by vulvar erythema, pruritus and abnormal vaginal discharge [1] [2] [3] . Approximately 5 % of infected women experience recurrence, with at least three symptomatic episodes of vaginitis over a period of 1 year [3, 4] . Although this disease is not linked to mortality, it can cause complications, and the psychological, physical and monetary costs can be significant [5, 6] . It has been estimated that three billion US$ was spent on diagnosing and treating the disease in the United States in 2014 [7] .
Among the yeasts that may cause VVC and RVVC, Candida albicans is the species that is most commonly involved, although a change in the incidence of other species is being observed [8, 9] . In recent years, the classification of Candida albicans has been subject to significant change, with the description of new species such as Candida dubliniensis and Candida africana, which are regarded as cryptic species complexes [10] [11] [12] . The epidemiological and clinical data presented to date show that C. africana has a worldwide distribution, having been isolated from vaginal specimens as well as from bloodstream, renal and systemic infections in China, Japan, the Republic of Korea, Colombia, Argentina and Iran [13] [14] [15] [16] .
Because of their heterogeneous morphological, biochemical and genetic characteristics, and owing to the fact that phenotypic identification systems do not allow discrimination between closely related Candida albicans species complexes, accurate identification of these isolates is often difficult [16, 17] . Masking such atypical Candida spp. can lead to overestimation of the epidemiology and clinical impact of C. albicans species [18] [19] [20] .
In spite of the global distribution of C. africana, the data on C. africana isolated from women with RVVC in Iran are scare [15] , and the extent of the infection caused by this species is unclear. Therefore, the present study was carried out to provide accurate insights into the microbial epidemiology of C. africana using clinical samples from RVVC patients. The phenotypic and genotypic characteristics of C. africana isolates were also described to clarify the phylogenetic aspects of the two species.
METHODS

Strains and phenotypic identification
This descriptive study was conducted over a period of 2 years between July 2014 and July 2016 on 750 symptomatic patients with suspected Candida vaginitis who had been referred to gynaecology and obstetrics clinics in Bushehr in the southern part of Iran. A total of 128 patients who had experienced at least 3 episodes of VVC within the preceding 12 months, as confirmed by clinical presentation and microscopic examination of samples for each episode, were considered as having RVVC. In the third episode, vaginal swabs were collected and kept in sterile saline and transferred to the Medical Mycology Laboratory at Bushehr University of Medical Sciences, where a 10 % KOH wet mount was prepared and observed microscopically to test for the presence of budding yeast cells. Another part of each sample was cultured on Sabouraud's dextrose agar (Merck, Germany) plates supplemented with 50 mg l À1 chloramphenicol and incubated at 37 C for 48 h. To ensure the purity of the isolates and for preliminary species identification, positive cultures were plated on CHROMagar Candida medium (CHROMagar, France) and incubated at 35 C for 48 h.
Species identification of yeast isolates was performed by conventional phenotypical procedures, including the germ tube test using human serum (37 C for 2 h) and cultivation on corn meal-Tween 80 agar (Difco Laboratories, Detroit, MI, USA) (28 C for 5 days), for visualization of chlamydospores and true hyphae.
Molecular identification of the isolates DNA was extracted and purified from colonies of all 128 isolates, as previously described [21] . Briefly, colonies were vortexed in a 1.5 ml tube containing 300 µl of lysis buffer (100 mM Tris-HCl, pH 7.5, 10 mM EDTA, 0.5 % w/v SDS, 100 mM NaCl), 300 µl of phenol/chloroform (1 : 1) and 300 µl of glass beads (0.5 mm in diameter), and centrifuged at 5000 r.p.m. for 5 min. The supernatant was submitted to DNA re-extraction using chloroform, and the DNA was precipitated with an equal volume of 2-propanol and 0.1 vol of 3 M sodium acetate (pH 5.2), kept at À20 C for 20 min and centrifuged at 10000 r.p.m. for 10 min. The pellet was washed with 300 µl of 70 % ethanol and air dried, and the DNA was eluted in 40 µl of distilled water. The DNAs were subjected to PCR-RFLP analysis as previously described [22] . Each PCR reaction contained 2 µl of template DNA, 0.5 µM of each of the universal primers (ITS1: 5¢-TCC GTA GGT GAA CCT GCG G-3¢ and ITS4: 5¢-TCC TCC GCT TAT TGA TAT GC-3¢), 12.5 µl of premix (Ampliqon, Denmark) and 9.5 µl of double-distilled water in a final volume of 25 µl to amplify the ITS1-5.8S-ITS2 rDNA region. The thermal conditions were as follows: 94 C for 6 min; 35 cycles of 94 C for 30 s, 58 C for 30 s and 72 C for 1 min; and a final extension step at 72 C for 10 min. Eight microlitres of PCR product were digested by incubation with 0.5 µl of the enzyme MspI (Fermentas, Vilnius, Lithuania), 1.5 µl of 10X buffer and 5 µl of water at 37 C for 3 h. The PCR amplicons and RFLP products were analysed by agarose gel electrophoresis in TBE buffer (Tris 0.09 M, Boric acid 0.09 M, EDTA 2 mM) at 100 V for approximately 60 min using 1.2 and 2 % agarose gels, respectively, containing 0.5 µg ml À1 ethidium bromide. For species identification, the sizes of the fragments generated by enzymatic digestion were compared with the those from the profiles described previously [22] . The specific patterns of common Candida species after restriction digestion by the restriction enzyme MspI are as follows: C. albicans (297, 338 bp), C. glabrata (557, 314 bp), C. tropicalis (340, 184 bp), C. krusei (261, 249 bp) and C. parapsilosis complex (520 bp) [22] .
Partial amplification of the HWPI gene and nucleotide sequence analysis The hyphal wall protein 1 (HWP1) marker was amplified to differentiate C. africana on the basis of the size of the amplicons specific to members of the C. albicans species complex, using the primers CR-f 5¢-GCT ACC ACT TCA GAA TCA TCA TC-3¢ and CR-r 5¢-GCA CCT TCA GTC GTA GAG ACG-3¢, as described previously [23] . The reactions were performed in final volumes of 25 µl containing 12.5 µl of premix (Ampliqon, Denmark), 0.5 µM of each primer, 3 µl of genomic DNA and 8.5 µl of water, using the following programme: 95 C for 5 min; 30 cycles of 94 C for 40 s, 58 C for 45 s and 72 C for 55 s; and a final extension step at 72 C for 10 min.
The PCR products of the isolates identified as C. africana were purified and subjected to sequencing by the ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction kit (Applied Biosystems, Foster City, CA, USA) on an automated DNA sequencer (ABI PrismTM 3730 Genetic Analyzer, Applied Biosystems) with the same primers as those used for PCR. The sequences were compared with valid reference sequences deposited in GenBank by BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi) analysis. DNA sequences were subjected to CLUSTALW pairwise alignment using Geneious software (http://www.geneious.com). Based on the different lengths and quality of the sequences, the common first and last points of the entire sequences were determined, and poorly aligned DNA sequences were removed. Edited sequences were subjected to BioEdit software version 7.0.5 [24] for pairwise comparisons and multiple alignments to determine the similarities and differences in the nucleotides. In order to assess the phylogenetic distance between C. africana and the related species from diverse geographical origins obtained from GenBank, a phylogenetic analysis of the HWP1 gene was performed. The Candida HWP1 DNA sequences obtained in this study and their predicted amino acid sequences were deposited in GenBank under the accession numbers MG434677-MG434688.
Antifungal susceptibility testing
The in vitro antifungal susceptibility of 10 C. africana strains to fluconazole (Sigma-Aldrich, St Louis, MO, USA) were assayed according to the recommendations in the Clinical and Laboratory Standards Institute (CLSI) M27-A3 and M27-S4 protocols [25, 26] . Candida parapsilosis (ATCC 22019) was used for quality control in the same manner and the in vitro susceptibilities of each strain were obtained using two independent replicates on different days.
RESULTS
From July 2014 to July 2016, a total of 128 clinical Candida strains isolated from women with RVVC were tested by conventional and molecular methods with a view to identifying the fungal species giving rise to the infection. Based on direct microscopic examination with 10 % KOH, isolates for which both blastospores and pseudohyphae were observed were considered to be C. albicans (92.96 %), and those isolates for which only blastospores were observed were classified as non-albicans species (7.04 %). Isolates of C. africana produced deeper turquoise/green colonies on CHROMagar Candida, and were thus different from the light green colonies of C. albicans (Fig. 1) . All of the examined C. africana strains formed germ tubes in human serum (3 h at 35 C) but failed to produce chlamydospores on corn meal agar with 1 % Tween 80 after 5 days of incubation at 28 C. According to the results of the PCR-RFLP analysis, 119 out of 128 isolates were determined to be C. albicans, which was thus by far the most commonly isolated species, followed by C. glabrata (9/128). All nine isolates that were recognized as C. glabrata by PCR-RFLP were confirmed by CHROMagar Candida. Among 119 presumptive isolates of C. albicans that were subjected to reidentification on the basis of HWP1 size polymorphisms, 109 were confirmed as being C. albicans (91.59 %), producing a DNA fragment of 900 bp, while 10 were classified as C. africana (8.4 %), producing a DNA fragment of 700 bp. The identification of these strains was confirmed by HWP1 sequencing. None of the isolates produced a DNA fragment of 569 bp, which would correspond to C. dubliniensis. Pairwise nucleotide alignment of entire HWP1 DNA sequences showed 100 % identity among Iranian C. africana strains. Comparison of the 10 Iranian C. africana HWP1 DNA sequences with the only 3 C. africana HWP1 DNA sequences available in GenBank (one from Iran, one from Italy and one from Argentina) revealed 99.7-100 % nucleotide sequence similarity. Comparison of the DNA sequences showed that C. africana isolates recovered from Italy (GenBank accession no. EU477610.1) and Argentina (GenBank accession no. KR704898.1) were genetically different from the Iranian strains, containing substitutions at positions 620 (CfiT) and 630 (TfiC), while the only Iranian strain available in GenBank, which was isolated from a patient in the north of Iran, exhibited 100 % genetic similarity to the strains identified in the present study. A maximum-likelihood phylogenetic tree of the HWP1 DNA sequences of the 10 Iranian C. africana isolates from the present study, the 3 C. africana DNA sequences available in GenBank and 2 representatives of Iranian C. albicans revealed that all 11 Iranian C. africana strains formed a cluster that was well separated from the rest of the C. africana sequences in GenBank (Fig. 2) . As shown in Table 1 , the C. africana isolates were susceptible to fluconazole, and the MIC range, GM MIC, MIC 50 and MIC 90 were 0.063-0.25, 0.12, 0.125 and 0.25 µg ml À1 , respectively.
DISCUSSION
This is the first report on C. africana in women suffering from recurrent Candida-related vaginitis in Iran. Although Candida africana is particularly related to superficial infections of the genital tract, its ability to cause deep-seated infections such as renal and bloodstream infections suggest its invasive potential [13] . Moreover, the differences in adherence ability, pathogenicity and biofilm formation observed between C. albicans and C. africana highlight the MIC, minimum inhibitory concentration; GM, geometric mean; MIC 50 , concentration at which 50 % of the isolates were inhibited; MIC 90 , concentration at which 90 % of the isolates were inhibited.
necessity of discriminating between them in clinical laboratories [13, 27, 28] .
C. africana is susceptible to conventional antifungal drugs, but resistance to flucytosine, voriconazole and terbinafine has recently been reported by Czaika et al. [29] and Al Hedaithy and Fotedar [30] . Furthermore, global overuse of azole antifungal agents without prescription for the treatment of Candida vaginal infection and repeated exposure to antifungal agents can lead to the induction of azole resistance in the strains, which may subsequently lead to candidaemia [31, 32] . Therefore, precise identification of the Candida isolates is essential to clarify the microbial epidemiological aspects of fungal vaginitis.
In this study, all of the patients (100 %) with suspected RVVC were culture-positive for Candida, which is a higher proportion than was found in studies by Rubia et al. [35] . Limited data have been published on the prevalence of non-albicans Candida species isolated from RVVC populations using molecular methods in Iran, which is possibly due to the focus on the preponderance of C. albicans infections in non-recurrent cases [36] .
In the current study, C. albicans had the highest incidence rate (92.96 %), followed by C. glabrata (7.04 %). Likewise, national and international studies conducted in different countries have reported that C. albicans is the most common species in cases of vaginal candidiasis (76-89 %), followed by C. glabrata (7-16 %) [37] [38] [39] [40] [41] [42] [43] . Other studies have found that C. tropicalis (26.4 %) is the most common nonalbicans species of vaginitis [44] [45] [46] . Although the prevalence of non-albicans species has increased, especially in chronic cases of vulvovaginal candidiasis, in the present study the overall prevalence of C. glabrata was significantly lower than that observed in several previous reports [47] [48] [49] . None of the isolates produced a 569 bp DNA fragment, which would be representative of C. dubliniensis, the species that is generally recovered from vaginal and oral samples, and its prevalence has usually been relatively low among VVC patients [10, 50] . The prevalence of C. dubliniensis appears to vary considerably among women with VVC infections, ranging from 0.2 to 30 % [37, 51, 52] . The differences may be explained by different clinical sample types, geographical differences and different identification methods; some methods may not always be suitable for discrimination between closely related Candida species [50, [53] [54] [55] .
Studies from various countries show that C. africana causes 0-40 % of vaginal yeast infections, with the prevalence depending on differences in geographical location and the ability to detect and identify the organisms [17, 35, 56, 57] .
In this study, strains of C. africana developed deeper turquoise/green colonies on CHROMagar, which differed from those of C. albicans, which were characterized by light turquoise/green colonies. However, colony colour variation in some C. albicans strains was also observed by Saunte et al. This can be affected by the unstable and subjective nature of phenotypic characteristics, which can be influenced by culture conditions [58] .
Pairwise nucleotide alignment of HWP1 DNA sequences highlighted the short length of the HWP1 DNA sequences of C. africana strains compared with the sequences of C. albicans. C. albicans and C. africana differ by less than 1 % across the ITS region [59] and only 1 % D1/D2 [60] , indicating two closely related species, while the HWP1 [23] and the rlm1 [61] genes have greater potential in terms of enabling differentiation between the species. Interestingly, although protein-coding genes are usually conserved between different species, the differences in the HWP1 DNA sequence length between C. albicans and C. africana are mainly due to length variation in the exon region.
Based on phylogenetic analysis of the HWP1 DNA sequences, all of the C. africana strains formed a well-supported cluster separated from C. albicans DNA sequences. Phylogenetic analysis of the 26S rRNA gene [60] , the 18S small subunit ribosomal RNA gene [16] and the ITS regions [59] demonstrated that C. africana isolates cannot be confidently separated from C. albicans strains based on these markers. The lack of intra-species variation observed among the Iranian C. africana strains is in accordance with the results inferred from the analysis of one of the most highly informative microsatellite loci, designed as CAI [61] , and from analysis of the 26S rRNA gene [60] , which showed a substantial degree of genetic similarity. Multi-locus sequence typing (MLST) has revealed a significant level of genetic similarity between C. africana strains; however, the Indian and Chinese strains in the study exhibited genetic variability at the mannose phosphate isomerase (MPIb) and a putative vacuolar protein (VPS13) locus [14] . In comparison to MLST, amplified fragment length polymorphism (AFLP) fingerprinting analysis yielded greater genetic diversity among the C. africana strains [14] . In our study, none of vaginal isolates of C. africana were fluconazole-resistant.
In conclusion, C. africana was detected in 7.8 % of the vaginal samples from patients with RVVC, which means that this species is not uncommon in such patients in Iran. While HWP1 size polymorphisms allowed us to differentiate C. africana from C. albicans, analysis of the HPW1 genes revealed no evidence of sequence variation within the C. africana isolates collected in the present study.
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